A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

about

Targeted therapy in sarcomas other than GIST tumors Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.Newer medical therapies for metastatic soft tissue sarcoma.

P2860

Q35622367-114D6F85-512B-4442-B12E-95A229B57573 Q37718554-52FC4FDB-EFD1-4A5F-AF77-7B825F33B19C Q39012067-14576388-CD21-4DB2-95A3-6B6C7583C2FC

P2860

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

Item

http://www.wikidata.org/entity/Q37061813

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

@en

A phase I study of the combina ...... otecan for metastatic sarcoma.

@nl

type

Item

label

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

@en

A phase I study of the combina ...... otecan for metastatic sarcoma.

@nl

prefLabel

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

@en

A phase I study of the combina ...... otecan for metastatic sarcoma.

@nl

P1476

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

@en

P2093

Ben Liem

http://www.w3.org/2001/XMLSchema#string

Berndt Schmit

http://www.w3.org/2001/XMLSchema#string

Monte Shaheen

http://www.w3.org/2001/XMLSchema#string

Robert H Quinn

http://www.w3.org/2001/XMLSchema#string

Sujana Movva

http://www.w3.org/2001/XMLSchema#string

Therese Bocklage

http://www.w3.org/2001/XMLSchema#string

Yongli Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent Inhibition of sirtuin 1

mTOR signaling in growth control and disease

Targeting the PI3K signaling pathway in cancer

RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs

Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.

Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.

P304

418-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS5020418

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claire F. Verschraegen

P577

2013-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258444387

http://www.w3.org/2001/XMLSchema#string

P698

24216984

http://www.w3.org/2001/XMLSchema#string

P932

3730334

http://www.w3.org/2001/XMLSchema#string

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

about

P2860

P2860

A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932